Multicenter trial of carperitide in patients with renal dysfunction undergoing cardiovascular surgery
Authors:
- 13 January 2012
- journal article
- research article
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 60 (1) , 21-30
Abstract
The aim of this study was to evaluate the efficacy of carperitide in maintaining renal function during intraoperative and postoperative management of patients with renal dysfunction undergoing elective cardiovascular surgery. The subjects were 88 patients with a preoperative serum creatinine level ≥1.2 mg/dl who underwent elective cardiovascular surgery using cardiopulmonary bypass. They were prospectively divided into a group that received carperitide from the start of surgery (carperitide group, n = 44) and a group that was not given carperitide (control group, n = 44). Carperitide infusion was initiated at the beginning of surgery and was continued for ≥5 days, with the central dose being 0.02 g/kg/min. The primary endpoint was the serum creatinine level on postoperative day (POD) 3. The serum creatinine levels on PODs 3, 4, and 7 were significantly lower, and creatinine clearance on PODs 2 and 3 was significantly higher in the carperitide group than in the controls. One patient in the control group and no patient in the carperitide group required continuous hemodiafiltration, but the difference was not statistically significant. Continuous low-dose infusion of carperitide from the start of cardiovascular surgery maintained renal function in patients with preoperative renal dysfunction.Keywords
This publication has 22 references indexed in Scilit:
- Atrial natriuretic peptide for preventing and treating acute kidney injuryCochrane Database of Systematic Reviews, 2009
- Influence of Continuous Infusion of Low-Dose Human Atrial Natriuretic Peptide on Renal Function During Cardiac SurgeryJACC, 2009
- Acute Kidney Injury Is Associated With Increased Long-Term Mortality After Cardiothoracic SurgeryCirculation, 2009
- Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humansIntensive Care Medicine, 2004
- Renal Dysfunction after Myocardial Revascularization: Risk Factors, Adverse Outcomes, and Hospital Resource UtilizationAnnals of Internal Medicine, 1998
- Preoperative Renal Risk StratificationCirculation, 1997
- Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgeryIntensive Care Medicine, 1996
- Effects of atrial natriuretic peptide in clinical acute renal failureKidney International, 1994
- Acute Renal Failure after Coronary Surgery - A Study of Incidence and Risk Factors in 2009 Consecutive PatientsThe Thoracic and Cardiovascular Surgeon, 1993
- Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.Circulation, 1987